Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct;111(4):345-366.
doi: 10.1007/s00223-022-00998-6. Epub 2022 Jun 29.

An Update on Animal Models of Osteogenesis Imperfecta

Affiliations
Review

An Update on Animal Models of Osteogenesis Imperfecta

Fang Lv et al. Calcif Tissue Int. 2022 Oct.

Abstract

Osteogenesis imperfecta (OI) is a heterogeneous disorder characterized by bone fragility, multiple fractures, bone deformity, and short stature. In recent years, the application of next generation sequencing has triggered the discovery of many new genetic causes for OI. Until now, more than 25 genetic causes of OI and closely related disorders have been identified. However, the mechanisms of many genes on skeletal fragility in OI are not entirely clear. Animal models of OI could help to understand the cellular, signaling, and metabolic mechanisms contributing to the disease, and how targeting these pathways can provide therapeutic targets. To date, a lot of animal models, mainly mice and zebrafish, have been described with defects in 19 OI-associated genes. In this review, we summarize the known genetic causes and animal models that recapitulate OI with a main focus on engineered mouse and zebrafish models. Additionally, we briefly discuss domestic animals with naturally occurring OI phenotypes. Knowledge of the specific molecular basis of OI will advance clinical diagnosis and potentially stimulate targeted therapeutic approaches.

Keywords: Mechanism; Mouse models; Osteogenesis imperfecta; Zebrafish models.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Marom R, Rabenhorst BM, Morello R (2020) Osteogenesis imperfecta: an update on clinical features and therapies. Eur J Endocrinol 183(4):R95–R106 - PubMed - PMC - DOI
    1. Tournis S, Dede AD (2018) Osteogenesis imperfecta—a clinical update. Metabolism 80:27–37 - PubMed - DOI
    1. Marini JC, Forlino A, Bächinger HP, Bishop NJ, Byers PH, Paepe A, Fassier F, Fratzl-Zelman N, Kozloff KM, Krakow D, Montpetit K, Semler O (2017) Osteogenesis imperfecta. Nat Rev Dis Primers 3:17052 - PubMed - DOI
    1. Forlino A, Marini JC (2016) Osteogenesis imperfecta. Lancet 387(10028):1657–1671 - PubMed - DOI
    1. Chetty M, Roomaney IA, Beighton P (2021) The evolution of the nosology of osteogenesis imperfecta. Clin Genet 99(1):42–52 - PubMed - DOI

Publication types

LinkOut - more resources